Effect of endoglin overexpression during embryoid body development

Experimental Hematology

Volumn 40, Issue 10, 2012, Pages 837-846

  Baik, June ^a   Borges, Luciene ^a   Magli, Alessandro ^a   Thatava, Tayaramma ^a,b   Perlingeiro, Rita C R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; DOXYCYCLINE; ENDOGLIN; GLOBIN; SMAD1 PROTEIN; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR TAL1;

ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; COLONY FORMING CELL; CONTROLLED STUDY; EMBRYO; EMBRYOID BODY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ERYTHROID CELL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HEART MUSCLE CELL; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MESODERM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE MORPHOGENETIC PROTEIN 4; CELL DIFFERENTIATION; CELL LINEAGE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; EMBRYOID BODIES; GATA1 TRANSCRIPTION FACTOR; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLOBINS; HEK293 CELLS; HEMATOPOIESIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; SMAD1 PROTEIN;

EID: 84866329004     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.06.007     Document Type: Article

References (43)

1. Barbara N.P., Wrana J.L., Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J Biol Chem 1999, 274:584-594.
2. Yamashita H., Ichijo H., Grimsby S., Moren A., ten Dijke P., Miyazono K. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-beta. J Biol Chem 1994, 269:1995-2001.
3. Cheifetz S., Bellon T., Cales C., et al. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 1992, 267:19027-19030.
4. Goumans M.J., Valdimarsdottir G., Itoh S., Rosendahl A., Sideras P., ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 2002, 21:1743-1753.
5. Lebrin F., Goumans M.J., Jonker L., et al. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J 2004, 23:4018-4028.
6. McAllister K.A., Grogg K.M., Johnson D.W., et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994, 8:345-351.
7. Johnson D.W., Berg J.N., Baldwin M.A., et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996, 13:189-195.
8. Carvalho R.L.C., Jonker L., Goumans M.J., et al. Defective paracrine signalling by TGF-beta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 2004, 131:6237-6247.
9. Lebrin F., Deckers M., Bertolino P., ten Dijke P. TGF-beta receptor function in the endothelium. Cardiovasc Res 2005, 65:599-608.
10. Bourdeau A., Dumont D.J., Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 1999, 104:1343-1351.
11. Arthur H.M., Ure J., Smith A.J., et al. Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 2000, 217:42-53.
12. Zhang L., Magli A., Catanese J., Xu Z., Kyba M., Perlingeiro R.C. Modulation of TGF-{beta} signaling by endoglin in murine hemangioblast development and primitive hematopoiesis. Blood 2011, 118:88-97.
13. Perlingeiro R.C. Endoglin is required for hemangioblast and early hematopoietic development. Development 2007, 134:3041-3048.
14. Iacovino M., Hernandez C., Xu Z., Bajwa G., Prather M., Kyba M. A conserved role for Hox paralog group 4 in regulation of hematopoietic progenitors. Stem Cells Dev 2009, 18:783-792.
15. Perlingeiro R.C.R., Kyba M., Bodie S., Daley G.Q. A role for thrombopoietin in hemangioblast development. Stem Cells 2003, 21:272-280.
16. Kennedy M., Firpo M., Choi K., et al. A common precurson for primitive erythropoiesis and definitive haematopoiesis. Nature 1997, 386:488-493.
17. Choi K., Kennedy M., Kazarov A., Papadimitriou J.C., Keller G. A common precursor for hematopoietic and endothelial cells. Development 1998, 125:725-732.
18. Wang D., Chang P.S., Wang Z., et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 2001, 105:851-862.
19. Sadlon T.J., Lewis I.D., D'Andrea R.J. BMP4: its role in development of the hematopoietic system and potential as a hematopoietic growth factor. Stem Cells 2004, 22:457-474.
20. Winnier G., Blessing M., Labosky P.A., Hogan B.L. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995, 9:2105-2116.
21. Yu P.B., Hong C.C., Sachidanandan C., et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 2008, 4:33-41.
22. Cho S.K., Bourdeau A., Letarte M., Zuniga-Pflucker J.C. Expression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursors. Blood 2001, 98:3635-3642.
23. Chen C.Z., Li M., de Graaf D., et al. Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells. Proc Natl Acad Sci U S A 2002, 99:15468-15473.
24. Roques M., Durand C., Gautier R., et al. Endoglin expression level discriminates long-term hematopoietic from short-term clonogenic progenitor cells in the aorta. Haematologica 2012, 97:975-979.
25. Wang Q., Stacy T., Binder M., et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A 1996, 93:3444-3449.
26. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996, 84:321-330.
27. Shivdasani R.A., Mayer E.L., Orkin S.H. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 1995, 373:432-434.
28. Robb L., Lyons I., Li R., et al. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci U S A 1995, 92:7075-7079.
29. Warren A.J., Colledge W.H., Carlton M.B., Evans M.J., Smith A.J., Rabbitts T.H. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 1994, 78:45-57.
30. Yamada Y., Warren A.J., Dobson C., Forster A., Pannell R., Rabbitts T.H. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc Natl Acad Sci U S A 1998, 95:3890-3895.
31. Pimanda J.E., Ottersbach K., Knezevic K., et al. Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development. Proc Natl Acad Sci U S A 2007, 104:17692-17697.
32. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996, 10:1580-1594.
33. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998, 67:753-791.
34. Aoki H., Fujii M., Imamura T., et al. Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci 2001, 114:1483-1489.
35. Zhang H., Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996, 122:2977-2986.
36. Mishina Y., Suzuki A., Ueno N., Behringer R.R. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 1995, 9:3027-3037.
37. Beppu H., Kawabata M., Hamamoto T., et al. BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev Biol 2000, 221:249-258.
38. Maeno M., Mead P.E., Kelley C., et al. The role of BMP-4 and GATA-2 in the induction and differentiation of hematopoietic mesoderm in Xenopus laevis. Blood 1996, 88:1965-1972.
39. Zhang C., Evans T. BMP-like signals are required after the midblastula transition for blood cell development. Dev Genet 1996, 18:267-278.
40. Huber T.L., Zhou Y., Mead P.E., Zon L.I. Cooperative effects of growth factors involved in the induction of hematopoietic mesoderm. Blood 1998, 92:4128-4137.
41. Sanchez M., Gottgens B., Sinclair A.M., et al. An SCL 3' enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors. Development 1999, 126:3891-3904.
42. Gottgens B., Nastos A., Kinston S., et al. Establishing the transcriptional programme for blood: the SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors. EMBO J 2002, 21:3039-3050.
43. Chung Y.S., Zhang W.J., Arentson E., Kingsley P.D., Palis J., Choi K. Lineage analysis of the hemangioblast as defined by FLK1 and SCL expression. Development 2002, 129:5511-5520.